Loading clinical trials...

High-dose ICE With Amifostine | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00003657

High-dose ICE With Amifostine

The purpose of the study is to evaluate the combination of amifostine and high dose chemotherapy with blood stem cell support. Amifostine is a druf developed to protect normal tissues against the toxi...

Lead sponsor: Dana-Farber Cancer Institute•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITING

DESTINY-PANTUMOUR04

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

RECRUITINGPhase 2

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

NCT06682728 · Urothelial Carcinoma, Muscle-invasive Bladder Cancer

RECRUITINGPhase 1

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more

RECRUITINGPhase 1

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

NCT07206225 · Non-muscle Invasive Bladder Cancer

RECRUITINGPhase 2

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

NCT07322263 · Bladder Cancer, Non-Muscle Invasive Bladder Cancer (NMIBC), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 20, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment24

Start dateJul 1998

Last updatedJan 20, 2017

Condition

Bladder Cancer Brain and Central Nervous System Tumors Carcinoma of Unknown Primary Extragonadal Germ Cell Tumor Head and Neck Cancer+6 more

Locations shown

Massachusetts General Hospital Cancer Center

Boston, Massachusetts

Dana-Farber Cancer Institute

Boston, Massachusetts

Beth Israel Deaconess Medical Center

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2017Data synced to Clareo: May 16, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

High-dose ICE With Amifostine

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

DESTINY-PANTUMOUR04

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Trial snapshot

Condition

Locations shown

For caregivers